Charles Schwab Investment Management Inc. Acquires 123,596 Shares of National Health Investors, Inc. (NYSE:NHI)

Charles Schwab Investment Management Inc. lifted its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 17.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 852,377 shares of the real estate investment trust’s stock after purchasing an additional 123,596 shares during the period. Charles Schwab Investment Management Inc. owned about 1.88% of National Health Investors worth $71,651,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in NHI. Strategic Financial Concepts LLC bought a new position in shares of National Health Investors during the second quarter valued at about $28,000. Covestor Ltd boosted its holdings in National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 405 shares during the period. International Assets Investment Management LLC bought a new position in National Health Investors during the 2nd quarter worth approximately $36,000. Blue Trust Inc. increased its stake in National Health Investors by 2,651.9% in the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 716 shares during the period. Finally, Assetmark Inc. lifted its position in National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 141 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

Shares of NYSE NHI opened at $76.91 on Friday. National Health Investors, Inc. has a 1 year low of $51.59 and a 1 year high of $86.13. The stock has a market capitalization of $3.49 billion, a P/E ratio of 26.43, a P/E/G ratio of 5.14 and a beta of 1.05. The company’s 50-day moving average is $79.01 and its 200 day moving average is $74.68. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. During the same quarter last year, the company posted $1.08 EPS. The firm’s revenue was up 1.7% on a year-over-year basis. On average, sell-side analysts expect that National Health Investors, Inc. will post 4.42 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.68%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 123.71%.

Analyst Ratings Changes

NHI has been the topic of several analyst reports. Truist Financial lifted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Bank of America began coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their target price for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $76.33.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.